Preclinical cardiac disease in women and men with primary aldosteronism

References

• Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993;88:1444–1455.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314–340.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019;25(11):1657–1666.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Sechi LA, Williams TA, et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38(10):1929–1936.
   PubMed Web of Science ®Google Scholar
• Fallo F, Pilon C, Urbanet R. Primary aldosteronism and metabolic syndrome. Horm Met Res. 2012;44(03):208–214.
   PubMedGoogle Scholar
• Ohno Y, Sone M, Inagaki N, et al. Obesity as a key factor underlying idiopathic hyperaldosteronism. J Clin Endocrinol Metab. 2018;103(12):4456–4464.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Paini A, et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension. 2008;52(3):529–534.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Di Bello V, Ganzaroli C, et al. Excess ldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension. 2002;40(1):23–27.
   PubMed Web of Science ®Google Scholar
• Freel EM, Mark PB, Weir RA, et al. Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circ Cardiovasc Imaging. 2012;5(6):740–747.
   PubMed Web of Science ®Google Scholar
• Milan A, Magnino C, Fabbri A, et al. Left heart morphology and function in primary aldosteronism. High Blood Press Cardiovasc Prev. 2012;19(1):11–17.
   PubMedGoogle Scholar
• Gerdts E, Okin PM, De Simone G, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51(4):1109–1114.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Izzo R, Mancusi C, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol. 2018;258:257–261.
   PubMed Web of Science ®Google Scholar
• Lønnebakken MT, Izzo R, Mancusi C, et al. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network). J Am Heart Assoc. 2017;6(3):e004152.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Zabalgoitia M, Björnstad H, et al. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol. 2001;87(8):980–983.
   PubMed Web of Science ®Google Scholar
• Tadic M, Cuspidi C, Grassi G. The influence of sex on left ventricular remodeling in arterial hypertension. Heart Fail Rev. 2019;24(6):905–914.
   PubMed Web of Science ®Google Scholar
• Funder J, Carey R, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266–3281.
   PubMed Web of Science ®Google Scholar
• Halland H, Lønnebakken M, Pristaj N, et al. Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). Nutr Metab Cardiovasc. 2018;28(10):1054–1060.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–271.
   PubMed Web of Science ®Google Scholar
• de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23(6):1444–1451.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur J Echocardiogr. 2016;17(12):1321–1360.
   Google Scholar
• Salvetti M, Paini A, Bertacchini F, et al. Myocardial mechano-energetic efficiency in primary aldosteronism. J Hypertens. 2021;139(2):318–324.
   PubMed Web of Science ®Google Scholar
• Chen Z-W, Huang K-C, Lee J-K, et al. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study. J Hypertens. 2018;36(2):353–360.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhu L-m, Xu J-z, et.al. Comparison of left ventricular structure and function in primary aldosteronism and essential hypertension by echocardiography. Hypertens Res. 2017;40(3):243–250.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996;27(5):1039–1045.
   PubMed Web of Science ®Google Scholar
• Mancusi C, Gerdts E, Losi MA, et al. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). Int J Cardiol. 2017;244:260–264.
   PubMed Web of Science ®Google Scholar
• Herfindal B, Gerdts E, Kringeland EA, et al. Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated Cardiovascular dysfunction study. J Hypertens. 2020;38(6):1158–1164.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Caroccia B, Seccia TM. Role of estrogen receptors in modulating aldosterone biosynthesis and blood pressure. Steroids. 2019;152:108486.
   PubMed Web of Science ®Google Scholar
• Kozàkovà M, Buralli S, Palombo C, et al. Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension. 2003;41(2):230–236.
   PubMed Web of Science ®Google Scholar
• Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50(5):911–918.
   PubMed Web of Science ®Google Scholar
• Spartera M, Damascelli A, Mozes F, et al. Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement. Int J Cardiol. 2017;33(9):1351–1360.
   Google Scholar
• Wang D, Xu J-Z, Chen X, et al. Speckle-tracking echocardiographic layer-specific strain analysis on subclinical left ventricular dysfunction in patients with primary aldosteronism. Am J Hypertens. 2019;32(2):155–162.
   PubMed Web of Science ®Google Scholar
• Orhan AL, Uslu N, Dayi SU, et al. Effects of isolated obesity on left and right ventricular function: a tissue Doppler and strain rate imaging study. Echocardiography. 2010;27(3):236–243.
   PubMed Web of Science ®Google Scholar
• Grytaas MA, Sellevåg K, Thordarson HB, et al. Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism. Endocr Connect. 2018;7(3):413–424.
   PubMed Web of Science ®Google Scholar